1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
Rheumatoid Arthritis Testing - North America Analysis and Market Forecasts

Rheumatoid Arthritis Testing - North America Analysis and Market Forecasts

  • June 2016
  • ID: 4149201
In this report:
While RA testing is one of the most lucrative segments within autoimmune testing, the market growth of RA testing will be hampered by the high rate of false positive results and the pressure for healthcare providers to control cost.
Moving forward, in light of increasing demand for RA testing, manufacturing companies are racing to develop the next-generation RA biomarkers that are have greater clinical accuracy.

Summary

Table of Contents

Rheumatoid Arthritis Testing - North America Analysis and Market Forecasts

Brief

The growing prevalence of rheumatoid arthritis, increase in healthcare expenditure globally, quickly increasing demand for autoimmune disease diagnostics, coupled with advancement in technology and the introduction of additional tests for example the second generation anti-cyclic citrullinated peptide immunoassays and the point of care lateral flow assays for RA diagnosis, are some of the main factors anticipated to drive market increase during the forecast period. Additionally, the US laboratories are adopting more automated systems as a more cost-effective alternative to manual testing, this will lead to an increase in the volume of RA tests performed in North America (NA). Also the implementation of initiatives aimed at developing effective diagnostic and therapeutic solutions for RA will further push for the development of suitable biomarkers.

While RA testing is one of the most lucrative segments within autoimmune testing, the market increase of RA testing will be hampered by the high rate of false positive results and the pressure for healthcare providers to control cost. Moving forward, in light of growing demand for RA testing, manufacturing companies are racing to develop the next-generation RA biomarkers that are have better clinical accuracy. A diagnostic test or a multi-biomarker panel that is capable of ruling out RA would be the ultimate goal for manufacturers.

The RA testing market is determined for North America continent: the U.S., Canada (CA) and Mexico (MX). This industry report offers insight into the adoption trends, market forces, challenging landscape, marketed and pipeline products, current and emerging players, as well as market outlooks. The market research determines the unmet needs in the sector while providing an understanding of physicians' perceptions in using and evaluating the adoption of various types of RA diagnostic tests.

*This is an on-demand report and will be delivered within 4 working days of the purchase.

Key Findings

Key questions & answers

- What is the current and future RA testing market outlook in the developed and emerging markets? What forecasts are affecting the North America market?

- What is the ambitious landscape and who are main players in the RA testing space?

- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are increasing the quickest?

- What are the unmet needs with the RA tests currently on the market? How will emerging technologies including POC assays fulfil these unmet needs?

- What are the main products and pipelines in the RA testing market?

- What are the challenges and barriers that have hindered widespread adoption of RA tests in distinct regions?

Great reasons to purchase

- "What Do Physicians Think" quotes provide a singular insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is vitally for all tactical decision makers in every organization permitting them to act on high quality information.

Please note: this report requires certain updates. We have all the information available but require 4 working days business days to complete the process and ensure it is as up-to-date as possible.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Nicolas helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Osteoarthritis Nutrition & Food Supplements Market

Global Osteoarthritis Nutrition & Food Supplements Market

  • $ 4250
  • Industry report
  • June 2018
  • by Mordor Intelligence LLP

The osteoarthritis nutrition & food supplements market is expected to register a CAGR of 3.85%. The factors propelling the growth of the market is rising demand for the geriatric population and increasing ...

Polyarticular Juvenile Idiopathic Arthritis (PJIA) Global Clinical Trials Review, H1, 2018

Clinical Research in Polyarticular Juvenile Idiopathic Arthritis (PJIA) in H1, 2018

  • $ 2500
  • Industry report
  • May 2018
  • by GlobalData

Polyarticular Juvenile Idiopathic Arthritis (PJIA) Global Clinical Trials Review, H1, 2018SummaryGlobalData’s clinical trial report, “Polyarticular Juvenile Idiopathic Arthritis (PJIA) Global Clinical ...

Gouty Arthritis (Gout) R&D Pipeline Analysis Report, H2-2018

Gouty Arthritis (Gout) R&D Pipeline Analysis Report, H2-2018

  • $ 2200
  • Industry report
  • August 2018
  • by VPAResearch

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studiesGouty Arthritis (Gout) Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information ...


ref:plp2016

Reportlinker.com © Copyright 2018. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on